Methylation-Dependent Gene Silencing Induced by Interleukin 1β via Nitric Oxide Production by Hmadcha, Abdelkrim et al.
 
1595
 
J. Exp. Med. 
 
Ó
 
 The Rockefeller University Press • 0022-1007/99/12/1595/09 $5.00
Volume 190, Number 11, December 6, 1999 1595–1603
http://www.jem.org
 
Methylation-dependent Gene Silencing Induced by 
Interleukin 1
 
b
 
 Via Nitric Oxide Production
 
By Abdelkrim Hmadcha, Francisco J. Bedoya, Francisco Sobrino,
and Elizabeth Pintado
 
From the Departamento de Bioquímica Médica y Biología Molecular, Facultad de Medicina y Hospital 
Universitario Virgen Macarena, Universidad de Sevilla, 41009 Sevilla, Spain
 
Summary
 
Interleukin (IL)-1
 
b 
 
is a pleiotropic cytokine implicated in a variety of activities, including dam-
age of insulin-producing cells, brain injury, or neuromodulatory responses. Many of these ef-
fects are mediated by nitric oxide (NO) produced by the induction of NO synthase (
 
iNOS
 
) ex-
pression. We report here that IL-1
 
b
 
 provokes a marked repression of genes, such as fragile X
mental retardation 1 (
 
FMR1
 
) and hypoxanthine phosphoribosyltransferase (
 
HPRT
 
),
 
 
 
having
 
 
 
a
CpG island in their promoter region. This effect can be fully prevented by iNOS inhibitors and
is dependent on DNA methylation. NO donors also cause 
 
FMR1 
 
and 
 
HPRT 
 
gene silencing.
NO-induced methylation of 
 
FMR1
 
 CpG island can be reverted by demethylating agents which,
in turn, produce the recovery of gene expression. The effects of IL-1
 
b
 
 and NO appear to be
exerted through activation of DNA methyltransferase (DNA MeTase
 
)
 
. Although exposure of
the cells to NO does not increase DNA 
 
MeTase 
 
gene expression, the activity of the enzyme se-
lectively increases when NO is applied directly on a nuclear protein extract. These findings re-
veal a previously unknown effect of IL-1
 
b
 
 and NO on gene expression, and demonstrate a novel
pathway for gene silencing based on activation of DNA MeTase by NO and acute modifica-
tion of CpG island methylation.
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M
 
ethylation status of control regions in the genome
plays a critical role in the regulation of gene expres-
sion (1–3). In susceptible genes containing 5
 
9
 
 CpG islands,
cytosine methylation favors a repressive chromatin struc-
ture that prevents the binding of transcriptional activators
to the promoter (4, 5). The molecular link between methyl
groups on the DNA and the positioning of nucleosomes to
form an inactive chromatin configuration has been recently
elucidated (6). Well-known examples of methylation-depen-
dent gene silencing are X-linked gene inactivation (7) and
genomic imprinting (8), and changes in the pattern of DNA
methylation occur during cell differentiation (9, 10) and
tumorigenesis (11–14). Hypermethylation of CpG islands
can be associated with the silencing of some genes, such as
fragile X mental retardation 1 (
 
FMR1
 
),
 
1
 
 causing inherited
mental diseases (15, 16). Differential genomic DNA meth-
ylation also has the potential to influence the development
of T cell cytokine production profiles (17). Here, we report
that exposure to IL-1
 
b
 
 (acting through inducible nitric ox-
ide synthase [
 
iNOS
 
] induction) or direct application of NO
donors induces in several cell types the suppression of the
expression of 
 
FMR1
 
 and other housekeeping genes con-
taining a CpG island in their promoter. This effect is shown
to be produced by DNA methylation resulting from acti-
vation of DNA methyltransferase (DNA MeTase). These
observations demonstrate that IL-1
 
b
 
 and NO, which are
messenger molecules involved in a wide variety of patho-
physiological processes, can have a direct effect on gene ex-
pression.
 
Materials and Methods
 
Materials.
 
IL-1
 
b
 
 and IFN-
 
g
 
 were purchased from Genzyme.
 
S
 
-nitroso-
 
N
 
-acetylpenicillamine (SNAP), 
 
N
 
-methyl arginine
(L-NMA and D-NMA), actinomycin D (ActD), trichostatin A
 
1
 
Abbreviations used in this paper:
 
 ActD, actinomycin D; AMT, 2-amino-5,6-
dihydro-6-methyl-4H-1,3-thiazine; AzadC, 5-aza-2
 
9
 
-deoxycytidine; 
 
b
 
-ME,
 
b
 
-mercaptoethanol; DNA MeTase, DNA methyltransferase; DTT, dithio-
threitol; EIT, 
 
S
 
-ethylisothiourea; 
 
FMR1
 
, fragile X mental retardation 1
gene; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GSH, glu-
tathione; HK, hexokinase; HPRT, hypoxanthine phosphoribosyltrans-
 
ferase; iNOS, inducible NOS; LDH, lactate dehydrogenase; L-NIL, 
 
l
 
-
 
N
 
6
 
-
(1-iminoethyl)-lysine; NF-
 
k
 
B, nuclear factor 
 
k
 
B; NMA, 
 
N
 
-methyl argi-
nine; NO, nitric oxide; NOS, NO synthase; PK, pyruvate kinase; RIN,
RINm5F; RT, reverse transcription; SIN, 3-morpholinosydnonimine hy-
drochloride; SNAP, 
 
S
 
-nitroso-
 
N
 
-acetylpenicillamine; SNP, sodium nitro-
prusside; SSPE, saline-sodium phosphate-EDTA; TSA, trichostatin A. 
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(TSA), 5-aza-2
 
9
 
-deoxycytidine (AzadC), dithiothreitol (DTT),
 
b
 
-mercaptoethanol (
 
b
 
-ME), and protease inhibitors were obtained
from Sigma Chemical Co. Sodium nitroprusside (SNP) was from
Fluka. 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine hydrochlo-
ride (AMT), 
 
S
 
-ethylisothiourea hydrobromide (EIT), and 
 
l
 
-
 
N
 
6
 
-
(1-iminoethyl)-lysine hydrochloride (L-NIL) were from Tocris
Cookson, Ltd. 3-morpholinosydnonimine hydrochloride (SIN) was
from ICN Iberica. Rediprime
 
®
 
 DNA labeling system, [
 
32
 
P]dCTP,
and cold and 
 
3
 
H-labeled 
 
S
 
-adenosylmethionine were from Ny-
comed Amersham plc. Glutathione (GSH) and poly deoxyinosine-
deoxycytosine (poly dI-dC) were from Boehringer Mannheim. Re-
striction enzymes were from Promega or New England Biolabs. All
other reagents were of the best quality commercially available.
 
Cell Culture.
 
Insulin-producing rat RINm5F (RIN) cell, Jurkat
T cell, and mouse leukemic monocyte-macrophage cell (RAW
264 cell) lines were grown in RPMI 1640 containing 10% heat-
inactivated fetal bovine serum, 2 mM 
 
l
 
-glutamine, 100 U/ml peni-
cillin, 100 
 
m
 
g/ml streptomycin, and 2.5 
 
m
 
g/ml amphotericin B
under 5% CO
 
2
 
 at 37
 
8
 
C. Human lymphocytes were obtained from
peripheral blood of healthy donors as reported previously (18).
 
Reverse Transcription PCR.
 
Total RNA was extracted from
cell lines or fresh peripheral lymphocytes by the guanidine phenol
method. RNA was reverse transcribed using random hexamers,
and the cDNA was amplified using specific primers. PCR ampli-
fication of the CGG repeats at the FRAXA site and KH domains
was carried as reported previously (18, 19). Amplification of hy-
poxanthine phosphoribosyltransferase gene (
 
HPRT
 
) in RIN cells
was assessed using murine primers. Human specific primers were
used for 
 
HPRT
 
 mRNA analysis in Jurkat T cells and fresh periph-
eral lymphocytes (7). Reverse transcription (RT)-PCR of 
 
ATP
 
-ase
or glyceraldehyde 3-phosphate dehydrogenase gene (
 
GAPDH
 
)
was used as control. PCR products were visualized on agarose gel
stained with ethidium bromide.
 
Northern and Western Blots.
 
Northern blot of 
 
FMR1
 
 gene was
performed using 10 
 
m
 
g total RNA and 10 ng/ml of human
 
FMR1
 
 cDNA probe labeled with [
 
a
 
-
 
32
 
P]dCTP. Hybridization
conditions were: 16 h at 42
 
8
 
C in 50% formamide, 6
 
3
 
 saline-
sodium phosphate-EDTA (SSPE), 5
 
3
 
 Denhardt’s solution, 0.5%
SDS, 100 
 
m
 
g/ml herring sperm DNA. Wash conditions were:
2
 
3
 
 SSPE, 0.1% SDS at room temperature and 0.1
 
3
 
 SSPE, 0.1%
SDS at 55
 
8
 
C. DNA 
 
MeTase
 
 expression was assayed with the same
protocol using a specific 5-kb cDNA probe. Northern blot of
 
iNOS
 
 and 
 
GAPDH
 
 was assayed by standard procedures. Western
blot analysis of DNA MeTase was performed using 20–40 
 
m
 
g of
nuclear protein extract resolved on 5% SDS-PAGE, transferred
onto polyvinylidene difluoride membrane, and subjected to im-
munodetection using a 1:2,000 dilution of primary antibody and
an enhanced chemiluminescence detection (13).
 
Southern Blot.
 
DNA samples were prepared from cultured cell
lines by standard procedures. 10 
 
m
 
g of genomic DNA was digested
overnight with the restriction enzymes EcoRI-EagI or HindIII-
SacII, EagI and SacII being sensible to methylation. Restriction
fragments were separated by electrophoresis on 0.8% agarose gel,
Southern blotted, and hybridized with radiolabeled StB12.3 probe
as described previously (20).
 
DNA MeTase Assay.
 
DNA MeTase activity was determined
in nuclear protein extracts by the assay developed by Adams et al.
(21) with minor modifications. Cells were lysed in buffer con-
taining 20 mM Tris-HCl, pH 8, 137 mM NaCl, 5 mM MgCl
 
2
 
,
5 mM EDTA, 10% glycerol, 1 mM PMSF, 10 
 
m
 
g/ml aprotinin,
10 
 
m
 
g/ml leupeptin, and 100 
 
m
 
g/ml RNase. After centrifuga-
tion, nuclear extracts were prepared by resuspension of the crude
nuclei in high salt buffer. 15–25 
 
m
 
g of proteins was incubated for
 
2 h at 37
 
8
 
C with 4 
 
m
 
g of poly (dI-dC) as template and 5.25 
 
m
 
M
 
3
 
H-labeled 
 
S
 
-adenosylmethionine (1 
 
m
 
Ci; Amersham Pharmacia
Biotech) as methyl donor. Reactions were stopped, proteins ex-
tracted, and DNA template was recovered by ethanol precipita-
tion. RNA was removed by resuspension of the precipitates in
NaOH; DNA was spotted on Whatman filters, dried, and then
washed with trichloroacetic acid (5%) followed by ethanol, then
ether. Filters were placed in the scintillation mixture, and DNA
MeTase activity was determined by scintillation counting. Results
were expressed as cpm per microgram of protein; all experiments
were performed in duplicate. Background levels were determined
in assays where poly (dI-dC) was omitted. Statistical analyses were
performed using Student’s 
 
t
 
 test.
 
Other Enzymatic Assays.
 
Lactate dehydrogenase (LDH) and
pyruvate kinase (PK) were measured by standard procedures in
the 12,000 
 
g
 
 supernatant of Jurkat T cell homogenate as described
previously (22). Hexokinase (HK) was measured in the homoge-
nate of Jurkat T cells as reported elsewhere (23). Statistical analy-
ses were performed using Student’s 
 
t
 
 test.
 
Cell Proliferation Assay.
 
Cellular proliferation was determined
by a colorimetric assay system using 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium (MTT) following the manufacturer’s in-
structions (Cell Proliferation Kit I; Boehringer Mannheim).
 
Results and Discussion
 
Fragile X syndrome, the most common form of heredi-
tary mental retardation (24), results from repression of the
 
FMR1
 
 gene due to the expansion of the CGG repeats in its
first exon and methylation of the 5
 
9
 
 CpG island. The latter
alteration appears to be the primary cause of the disease,
since hypermethylation of the CpG island in the active X
chromosome is only observed in affected individuals,
whereas there are cases with full expansion of the CGG re-
peats but with an unmethylated island that do not manifest
the syndrome (25, 26). Furthermore, in vitro reactivation
of the 
 
FMR1
 
 gene by demethylating agents has been re-
ported recently (27). We have observed a marked inhibi-
tory effect of IL-1
 
b
 
 on 
 
FMR1
 
 gene expression in RIN cells
assessed by RT-PCR of both KH domains and CGG re-
peats (Fig. 1, a–c). Inhibition of 
 
FMR1
 
 expression was ap-
preciable after 12 h of incubation with IL-1
 
b
 
, and complete
suppression of the gene resulted with longer exposures
(Fig. 1 a). Since IL-1
 
b
 
 is known to be a powerful stimulus
for induction of 
 
NOS
 
 in RIN and other cell types (28, 29),
we investigated whether NO acted as a mediator of 
 
FMR1
repression. Fig. 1 b shows that SNP, an NO donor, mimics
the action of IL-1b, and that the IL effect is fully prevented
by the simultaneous addition of L-NMA, an inhibitor of
NOS activity. This preventive effect was not observed when
we used D-NMA (not shown). To further demonstrate that
IL-1b exerts gene silencing via NO production, we used
specific iNOS inhibitors such as AMT, EIT, and L-NIL
and found that all of them also prevented the action of
IL-1b (Fig. 1 c). To determine if FMR1 mRNA stability
was altered by NO, ActD was used to inhibit RNA synthe-
sis. As shown in Fig. 1 d, the time course of FMR1 mRNA
degradation was not modified by the presence of SNP.
Thus, production of NO by IL-1b or addition of NO pre-1597 Hmadcha et al.
cursors can produce FMR1 gene silencing. In preliminary ex-
periments, we have observed that IFN-g, which induces NO
synthesis, as well as NO donors can also inhibit FMR1 expres-
sion in a monocyte-macrophage cell line (RAW 264 cells).
To elucidate the mechanisms underlying the effect of NO
on gene regulation, we studied the expression of FMR1 in
human cells (Jurkat T cells and fresh lymphocytes) where
the complete map of the FMR1 promoter is known (30).
Although these cells are not stimulated by IL-1b, the appli-
cation of NO precursors (500 mM SNP and 100 mM SIN)
resulted in complete suppression of FMR1 expression (Fig.
2 a; see also Fig. 3 b), thus allowing a more detailed analysis
of the repression of FMR1 gene by NO. Since it has been
reported that NO can produce DNA damage by disruption
of nucleotide bonds (31), we tested if the effect of NO
could be explained by direct interaction with CG sites, par-
ticularly abundant in (CGG)n repeats and CpGs of FMR1.
The fact that we were unable to induce CG cleavage in the
FMR1 gene by NO donors in cellular and cell-disrupted
preparations (not shown) led us to hypothesize that NO
could be part of a signaling pathway regulating methylation
of the CpG island in the FMR1 promoter region. This was
tested by Southern blot using methyl-sensitive restriction
enzymes and the StB12.3 probe currently applied to study
the length and the methylation status of FMR1 in fragile X
patients (20, 24). Fig. 2 b shows that treatment of Jurkat T
cells with SNP or SIN produced full CpG island methyla-
tion (lanes 2, 4, and 6), which was totally prevented when
the cells were treated with the demethylating agent AzadC
in the presence of any of the NO donors (lanes 3 and 5). In
the experiments where we applied an NO donor (or IL-1b)
plus AzadC, we incubated the cells for 24 h as has been rec-
Figure 1. FMR1 expression in RIN cells treated with
IL-1b and NO donors. In this and other figures, RT-PCR
of KH domains and CGG repeats of FMR1 give bands of
500 and 242 bp, respectively; Na/K ATP-ase (250 bp) and
GAPDH (600 bp) were used as control. (a) Time course of
IL-1b (25 U/ml) induced FMR1 repression in RIN cells.
(b) 16 h treatment with IL-1b (25 U/ml), SNP (100 mM),
or IL-1b (25 U/ml) plus NMA (100 mM). (c) 16 h treat-
ment with IL-1b (25 U/ml) or IL-1b plus a specific iNOS
inhibitor (20 nM AMT, 100 nM EIT, or 10 mM L-NIL).
(d) Different exposure times of RIN cells with ActD
alone (5 mg/ml) or added simultaneously with SNP (100
mM). Data shown in this and the other figures are repre-
sentative of two to six experiments.
Figure 2. NO-induced FMR1 silencing and methyla-
tion of FMR1 CpG island in Jurkat T cells. (a) RT-PCR
of FMR1 KH domains after 16 h incubation with SNP
(500 mM) or SIN (100 mM). GAPDH was used as
control. (b) Southern blot of genomic DNA digested
to completion with EcoRI-EagI. The 2.8-kb fragment
results from cleavage by both enzymes, whereas the
5.2-kb fragment corresponds to digestion with EcoRI,
indicating protection from restriction by methylation.
Untreated cells (lane 1); cells incubated for 24 h with
SNP (500 mM) or SIN (100 mM) (lanes 2 and 4); cells
treated for 24 h simultaneously with SNP (500 mM)
plus AzadC (2 mg/ml) or SIN (100 mM) plus AzadC
(2 mg/ml) (lanes 3 and 5); cells incubated for 16 h with
SIN (100 mM) (lane 6); and cells exposed for 16 h to
SIN (100 mM), washed, and incubated for 24 h with
AzadC (2 mg/ml) (lane 7). (c) Methylation pattern in-
duced by 3, 4, 5, or 6 h incubation with SNAP (100
mM). (d) DNA MeTase activity in RIN and Jurkat T
cells treated for 16 h with IL-1b (25 U/ml) and for 6 h
with SIN (100 mM), respectively, expressed as cpm/mg
protein (100 cpm/mg protein corresponds to a specific
activity of 0.015 pmol/h/mg protein).1598 Nitric Oxide Production and Methylation-dependent Gene Silencing
ommended when using the demethylating agent (7). After
incubation with and washout of SIN, addition of AzadC also
reverted the methylating action of NO (lane 7), indicating
that the effect of AzadC was not due to direct chemical inter-
action with SIN. CpG methylation induced by NO donors
(SIN or SNAP) progressed with time after the initial 3 h of
treatment, and full methylation was observed at 6 h (Fig. 2 c).
To further investigate the NO-dependent methylation
process, we measured the activity of DNA MeTase, the
major DNA methylating enzyme that produces 59 methyl-
cytosine (32). Incubation of RIN cells with IL-1b increased
DNA MeTase activity to about twice the level found in
control cells (P , 0.001, n 5 3). A qualitatively similar ef-
fect was observed in Jurkat T cells exposed to an NO do-
nor (P , 0.001, n 5 3; Fig. 2 d). These increases in activity
are within the range of those recently published in trans-
formed rodent cells overexpressing c-fos (33). Since NO-
induced methylation of the CpG island is abolished by the
presence of the demethylating agent AzadC (see Fig. 2 b),
it is expected that addition of this product would prevent
FMR1 silencing induced by either IL-1b or NO. Fig. 3 a
illustrates that FMR1 suppression produced by IL-1b was
almost completely reverted by incubation with the demethy-
lating agent. It is also shown that AzadC did not diminish the
level of expression of iNOS induced by IL-1b. Similarly,
demethylation also prevented FMR1 suppression resulting
from exposure of the cells to NO donors (Fig. 3 b). These
data indicate that NO-dependent FMR1 gene silencing re-
sults from methylation of the CpG island, an effect medi-
ated by activation of DNA MeTase.
The major mammalian DNA MeTase is a large protein
with an NH2-terminal putative regulatory domain com-
prising two thirds of the protein with eight cysteine resi-
dues, and a COOH-terminal catalytic domain with the ad-
enosylmethionine binding region and a proline-cysteine
catalytic center (34). The signals and mechanisms involved
in regulation of DNA MeTase activity are poorly under-
stood. The NH2 terminus is unnecessary for catalysis, but
its cleavage from the COOH terminus causes a large stimu-
lation of the initial velocity of methylation of unmethylated
DNA (34). The NH2 terminus contains a major phosphor-
ylation site (serine 514) although its relevance in catalysis is
uncertain, since treatment of the enzyme with phosphatases
and kinases results in no significant effect on the catalytic
rate (35). We assayed whether the effect of NO on DNA
MeTase activity was due to activation of guanyl cyclase, by
incubation of Jurkat T cells with 2 mM dibutyryl cGMP
for 24 h. cGMP had no effect on either DNA MeTase ac-
tivity or the expression of FMR1 gene (not shown). The
Ras signaling pathway has been shown to increase DNA
MeTase transcription (36), and recently it has been sug-
gested that fos may transform cells through alterations in
DNA methylation (33). Therefore, we tested if the expres-
sion of DNA MeTase could be altered by exposure of Jur-
kat T cells to an NO donor. Northern and Western blot
analyses, shown in Fig. 4, a and b, respectively, indicate
that NO does not affect the expression of the major human
DNA MeTase. We have not studied the expression of the
recently described DNA MeTase3A and DNA MeTase3B
(37); however, it is very unlikely that they mediate the ef-
fects of NO described here, since these two enzymes are
present mainly in embryonic tissues (37). Moreover, NO
was able to activate DNA MeTase in a nuclear protein ex-
tract (see below), thus strongly suggesting that the regulation
of the enzyme by NO is not dependent on transcription.
The Western blot in Fig. 4 b also shows that NO did not
modify the magnitude or size of any of the bands obtained
with the polyclonal antibody against the DNA MeTase,
thus indicating that cleavage of the NH2-terminal regula-
tory domain is probably not involved in the mechanism of
action of NO. However, the presence of several cysteine
residues in the protein suggested the possibility of a direct
reaction of NO with thiols. Fig. 5 a shows that application
of an NO donor (SNAP) to a nuclear protein extract in-
duced a dose-dependent increase of DNA MeTase activity.
In addition, sodium nitrite and peroxynitrite at different
concentrations did not increase the enzymatic activity. On
the contrary, high concentration of peroxynitrite drastically
inhibited the reaction. Fig. 5 b illustrates the time course of
DNA MeTase activation induced by 50 mM of different
NO donors (SNAP, SIN, and SNP) in the nuclear protein
extract. In all cases, after 3 h incubation with the NO do-
nor a statistically significative increase in the DNA MeTase
activity was observed (P , 0.001, n 5 3 for SNAP; P ,
Figure 3. FMR1 expression in RIN and Jurkat T cells incubated with
IL-1b or NO donors and the demethylating agent AzadC. (a) Northern
blot of FMR1 and iNOS in RIN cells incubated for 24 h with IL-1b (25
U/ml) in the absence or presence of AzadC (2 mg/ml). (b) Northern blot
of FMR1 in Jurkat T cells following the same protocol as in the legend to
Fig. 2 b, except for the condition shown in lane 6. GAPDH expression
was used as control.
Figure 4. Effect of NO on the expression of DNA MeTase in Jurkat T
cells. (a) Northern blot of DNA MeTase in cells incubated for 16 h with
100 mM SNAP. FMR1 and GAPDH were used as control. (b) Western
blot of DNA MeTase using a polyclonal antibody in cells incubated for
16 h with 100 mM SNAP.1599 Hmadcha et al.
min/mg protein for LDH, 12 6 5 (n 5 3) pmol/min/mg
protein for HK, and 27 6 11 (n 5 3) pmol/min/mg protein
for PK. Table I shows that whereas 50 mM SNAP induced a
marked increase in DNA MeTase activity, it had no effect on
the activities of any of the other enzymes studied. Thus, in
cell extracts, NO exerts a selective effect on DNA MeTase.
Given that the inhibitory effect of NO on FMR1 ex-
pression can be explained by activation of DNA MeTase
and methylation of the CpG island, we explored if a similar
action is exerted on other genes, such as HPRT, known to
contain a CpG island in the promoter region. Fig. 6 shows
that exposure of RIN and Jurkat T cells to IL-1b (a) and
NO donors (b), respectively, resulted in abolishment of
HPRT expression. In both cases, demethylation with AzadC
produced recovery of gene expression. NO-dependent
methylation of CpG islands observed in transformed cells
(such as RIN and Jurkat T cells) was also clearly apparent in
fresh human lymphocytes. Fig. 6 c illustrates the silencing
of FMR1 and HPRT genes by NO donors and the rever-
sion of this effect by AzadC. The expression of genes such
as GAPDH or Na/K ATP-ase, which do not contain CpG-
rich promoters, is unaffected by NO (Fig. 6, a–c; see also
Figs. 1–3).
Table I. Effect of NO on the Activity of Several Cellular Enzymes
DNA MeTase LDH HK PK
Activity induced by SNAP
(% of control) 366 6 90* (n 5 6) 105 6 17 (n 5 5) 100 6 1 (n 5 3) 107 6 12 (n 5 3)
Cell extracts were incubated with 50 mM SNAP for 3 h. Results are expressed by mean 6 SEM of independent experiments in duplicate (number
of experiments in parenthesis.
*Value significantly different from the corresponding control.
0.001, n 5 2 for SIN and SNP); however, no change was
obtained when expired SNAP or SIN was used (more than
eight half-lives). Thiol oxidation independent of NO did not
seem to play a role in the action of NO donors on DNA
MeTase activity, since similar effects were seen when su-
peroxide dismutase and catalase were added to the reaction
mixture (not shown). Enhancement of DNA MeTase ac-
tivity induced by SNAP was completely reversed by fur-
ther incubation, after washout of the NO donor, with re-
ducing agents such as DTT, GSH, or b-ME (Fig. 5 c).
These results strongly suggest that NO, either directly or
through mediators present in the nuclear extract, regulates
DNA MeTase activity possibly by nitrosation of some cys-
teines present in the protein.
To evaluate the selectivity of the stimulatory effect of NO
on DNA MeTase, we measured in cell extracts the activity of
other enzymes, such as lactate dehydrogenase (LDH), hexo-
kinase (HK), and pyruvate kinase (PK), encoded by genes
that are constitutively expressed in all cells and are involved in
housekeeping functions. Cell extracts were incubated for 3 h
in the absence or presence of the stimulus. Basal activities
(given by mean 6 SD) were 0.02 6 0.006 (n 5 6) pmol/
h/mg protein for DNA MeTase, 110 6 22 (n 5 5) pmol/
Figure 5. Effect of NO on DNA MeTase activity in a nuclear protein extract of Jurkat T cells. (a) Dose-dependent effect of 3 h incubation with
SNAP (d), sodium nitrite (j), and peroxynitrite (m) on the activity of DNA MeTase. (b) Time course of DNA MeTase activity in the presence of 50
mM SNAP (d), SNP (j), SIN (m), expired SIN (.), or expired SNAP (r). Values in plots a and b are expressed in percentage of control values by
mean 6 SEM of three or two independent experiments in duplicate. (c) Effect of reducing agents on DNA MeTase activity stimulated by 50 mM SNAP.
The nuclear protein extract was incubated for 3 h without (control) or with 50 mM SNAP. Nuclear protein extracts were recovered, after washing, by
centrifugation or by filtration in a Sephadex G-25 spin column. Samples were further incubated for 2 h with no addition (control and SNAP) or in the
presence of 5 mM DTT (SNAP/DTT), 100 mM GSH (SNAP/GSH), or 100 mM b-ME (SNAP/b-ME). Values are expressed in percentage of control
values by mean 6 SEM of at least three independent experiments in duplicate. All the values of DNA MeTase activity in the presence of the reducing
agents were significantly different (P , 0.001) from the value of enzymatic activity in the absence of the agents. The average DNA MeTase activity in
basal conditions was 0.017 6 0.005 (n 5 15) pmol/h/mg protein. In each experiment, the basal DNA MeTase activity was set to 100%.1600 Nitric Oxide Production and Methylation-dependent Gene Silencing
NO-induced DNA methylation was maintained for sev-
eral hours after washout of the signal; however, it was a re-
versible phenomenon. In mitotically active cells (such as
Jurkat T cells) previously exposed to NO donors, a unique
and methylated band was observed by Southern blot 48 h
after removal of the stimulus, whereas after 72 h two bands,
methylated and unmethylated, were present (Fig. 7 a). Af-
ter 48 or 72 h incubation, we observed a clear increase in
the number of cells (Fig. 7 b). These results indicate that
DNA methylation appears to be transient, due to either loss
of methylation in the new generation of dividing cells or
the existence of active DNA demethylation. This latter
mechanism is suggested by the fact that reversibility of
NO-induced methylation was also observed in nondividing
cells such as quiescent fresh lymphocytes (not shown), and
is in accordance with a recent report describing the exist-
ence of DNA demethylases in human cells (38).
DNA methylation causes repression of gene expression
by promoting the condensation of chromatin. Methylated
sites on DNA bind the 5-methylcytosine binding protein
(MeCP2) that exists in a complex with Sin3A and histone
deacetylase, resulting in a compact chromatin structure (6).
To investigate whether NO-mediated gene silencing re-
quires histone deacetylation, we tested the effect of TSA, an
inhibitor of deacetylases (33). Fig. 7, c and d, show that sup-
pression of FMR1 expression (determined by both North-
ern blot and RT-PCR, respectively) was prevented by in-
cubation of the cells with 2 mM TSA, hence supporting the
view that NO-induced gene repression is due to increased
recruitment of histone deacetylases by methylated DNA.
NO is a broadly distributed signaling molecule involved
in numerous physiological and pathophysiological processes
(39–41), but its action on the genome is poorly under-
stood. Moreover, many actions of IL-1b are mediated by
the induction of iNOS and the resulting NO production
(42, 43). We show that by activating DNA MeTase, NO
can induce methylation of 59 CpG islands and, hence, re-
press gene expression. Methylation/demethylation of DNA
is known to be associated with X-linked gene inactivation,
imprinting, and fragile X syndrome (7, 8, 15). Changes in
DNA methylation are also observed during development,
the acquisition of T cell cytokine production profiles, and
tumorigenesis (9–14, 17), and several transcription factors
actively promoting DNA demethylation have been reported
(9, 44). Our findings provide the first case of FMR1 gene
Figure 7. Reversibility of CpG island methylation in di-
viding cells and reversion of FMR1 expression by a
deacetylase inhibitor. (a) Jurkat T cells were incubated for
16 h with 100 mM SNAP. Methylation of the CpG island
of FMR1 was measured by Southern blot at 48 and 72 h
after washout of the stimulus. Control cells were treated in
the same way but without exposure to SNAP. (b) Cell
number was measured in the same experimental conditions
as in a, with the MTT cell proliferation kit. (c) Northern
blot of FMR1 in Jurkat T cells incubated for 24 h in the
absence or presence of 2 mM TSA, an inhibitor of deacety-
lases. (d) RT-PCR of KH domain of FMR1 in the same
experimental conditions as in c. In both cases, GAPDH
was used as control.
Figure 6. HPRT expression in RIN and Jurkat T cells assessed by
RT-PCR. (a) RIN cells unstimulated and treated for 24 h with IL-1b
(25 U/ml) in the absence or presence of AzadC (2 mg/ml). (b) Similar
protocol used with Jurkat T cells stimulated with 100 mM SIN. (c)
RT-PCR of FMR1 and HPRT from fresh peripheral lymphocytes incu-
bated for 24 h with SIN (100 mM) in the absence or presence of AzadC
(2 mg/ml). RT-PCR of GAPDH was used as control.1601 Hmadcha et al.
silencing in situations other than fragile X syndrome, al-
though the methylation status in the two conditions shows
some differences. Methylation induced by NO was lost
with time, and TSA reversed the inhibitory effect on gene
expression induced by NO (see above). In contrast, it has
been recently reported that TSA has no effect on transcrip-
tion in cells from fragile X patients due to additional modifica-
tions in histone–DNA association (45). The marked repressive
effect of IL-1b and NO on the expression of housekeeping
genes, such as FMR1 and HPRT, with a CpG island in the
promoter might be part of a general adaptive mechanism
triggered in cells challenged by stressing situations.
It has been reported that nuclear factor kB (NF-kB) in
B cells can induce specific demethylation of the Igk locus
(46), and in some cells, including RIN cells, IL-1b recep-
tor stimulation induces a cascade that activates NF-kB (47,
48). In this work, we have shown that IL-1b clearly represses
gene expression by a mechanism involving methylation.
Our data indicate that the possible demethylating activity
of NF-kB in RIN cells does not counterbalance the in-
crease in activity of the DNA MeTase. Similarly, in Jurkat
T cells the incubation with PMA plus a calcium ionophore
(A23187), which induce NF-kB (49), does not prevent the
inhibitory action of NO on gene expression (results not
shown). However, it could be speculated that IL-1b transi-
torily represses housekeeping genes having CpG islands via
NO production and methylation while inducing tissue/
stage-specific gene expression by activating demethylation
via NF-kB. For instance, it has been reported that Ras in-
duces an increase in demethylase activity in parallel to its
induction of transcription of DNA MeTase (36).
Methylation of cytosine also gives an explanation for the
high occurrence of genomic C–T transitions observed un-
der exposure to NO (50). The abundance of 5-methylcyto-
sine in methylated DNA favors the transition to thymine
by simple deamination, which can occur spontaneously and
is potentiated by NO (51). Finally, given the resemblance
between certain viruses and housekeeping promoters (1),
the reported antiviral action of NO (52) could be explained
by methylation-dependent silencing of the viral genome.
Interestingly, DNA MeTase is a housekeeping gene with-
out 59 CpG island and, thus, its expression is insensitive to
NO (see above). In contrast, it has a specific promoter con-
taining activating protein (AP)-1, AP-2, and glucocorticoid
response elements (53), suggesting a potentially high level
of regulation by cellular signal transduction pathways.
In conclusion, we report here a novel action of IL-1b
mediated by NO production. NO induces a posttranscrip-
tional increase in the activity of DNA MeTase, resulting in
CpG island methylation and suppression of gene expression.
These results give new insights into the pathophysiological
regulation of genes with CpG-rich promoters.
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